Alliance Pharma's Recent Trading Activity: Key Insights
Alliance Pharma's Recent Trading Activity
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER
Rule 8.5 of the Takeover Code (the 'Code')
Key Information
(a) Name of exempt principal trader: Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Alliance Pharma plc
(c) Name of the party to the offer with which exempt principal trader is connected: Investec is the financial advisor to Aegros Bidco Limited, which is indirectly owned by DBAY Affiliates and the ERES IV Fund.
(d) Date dealing undertaken: 25th March 2025
(e) Additional disclosures regarding other parties involved in the offer: N/A
Dealings by the Exempt Principal Trader
The trading activities conducted by Investec include both purchases and sales of securities pertinent to Alliance Pharma. The currency of all prices and amounts discussed will be specified where applicable.
Purchases and Sales
Class of Relevant Security: Ordinary shares
Type of Dealings:
- Purchases: 520,121 shares at a highest price of 64.13 and a lowest price of 64.1.
- Sales: 500,000 shares at a price of 64.1.
Cash-Settled Derivative Transactions
Details: N/A
Stock-Settled Derivative Transactions (Including Options)
Writing, Selling, Purchasing, or Varying
Class of Relevant Security: N/A
Exercise
Details: N/A
Other Dealings
Details: N/A
Other Information
Indemnity and Other Dealing Arrangements
No agreements or understandings exist that may induce trading.
Agreements Relating to Options or Derivatives
No agreements or arrangements regarding voting rights or acquisition of relevant securities.
Date of disclosure: 26th March 2025
Contact Name: Priyali Bhattacharjee
Telephone Number: +91 9768034903
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation regarding the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website.
Frequently Asked Questions
What is the purpose of the form?
This form serves to disclose trading activities of exempt principal traders in relation to specified securities.
Who is the exempt principal trader mentioned?
The exempt principal trader in this case is Investec Bank plc.
What are the recent trading activities of Alliance Pharma?
The recent transactions include purchases and sales of ordinary shares by Investec Bank plc.
How many shares were purchased and sold?
A total of 520,121 shares were purchased, and 500,000 shares were sold.
Where can I find more information about the Code?
The Code is available for viewing on the Panel's official website.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
